Loss of imprinting in IGF2 in colorectal carcinoma assessed by microdissection

Oncology Reports

Volumn 15, Issue 4, 2006, Pages 791-795

  Maenaka, Shiori ^a   Hikichi, Tetsurou ^a   Imai, Miwa A ^b   Minamoto, Toshinari ^c   Kawahara, Ei ^a  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

^b ISHIKAWA PREFECTURAL NURSING UNIVERSITY   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

Author keywords

Colorectal carcinoma; Genomic imprinting; Insulin like growth factor II gene; Microdissection

Indexed keywords

DNA; ENDODEOXYRIBONUCLEASE APAI; SOMATOMEDIN B; TYPE II SITE SPECIFIC DEOXYRIBONUCLEASE;

ARTICLE; BINDING SITE; COLORECTAL TUMOR; GENETIC POLYMORPHISM; GENETICS; GENOME IMPRINTING; HUMAN; INTESTINE MUCOSA; LASER; METABOLISM; METHODOLOGY; MICRODISSECTION; PATHOLOGY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

BINDING SITES; COLORECTAL NEOPLASMS; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; DNA, NEOPLASM; GENOMIC IMPRINTING; HUMANS; INSULIN-LIKE GROWTH FACTOR II; INTESTINAL MUCOSA; LASERS; MICRODISSECTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 33746446922     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.15.4.791     Document Type: Article

References (27)

1. Falls JG, Pulford DJ, Wylie AA and Jirtle RL: Genomic imprinting: implications for human disease. Am J Pathol 154: 635-647, 1999. (Pubitemid 29122582)
2. Feinberg AP: Imprinting of a genomic domain of 11p15 and loss of imprinting in cancer: an introduction. Cancer Res 59: S1743-S1746, 1999.
3. Randyac LJ: Genomic imprinting and cancer. Exp Cell Res 248: 18-24, 1999.
4. Ohlsson R, Nystrom A, Pfeifer-Ohlsson S, Tohonen V, Hedborg F, Schofield P, Flam F and Ekstrom TJ: IGF2 is parentally imprinted during human embryogenesis and in the Beckwith-Wiedmann syndrome. Nat Genet 4: 94-97, 1993. (Pubitemid 23165921)
5. Sakatani T, Kaneda A, Lacobuzio-Donahue CA, Carter MG, Witzel SB, Okano H, Ko MSH, Ohlsson R, Longo DL and Feinberg AP: Loss of imprinting of IGF2 alters intestinal maturation and tumorigenesis in mice. Science 307: 1976-1978, 2005. (Pubitemid 40404709)
6. Kinouchi Y, Hiwatashi N, Higashioka S, Nagashima F, Chida M and Toyota T: Relaxation of imprinting of the insulin-like growth factor II gene in colorectal cancer. Cancer Lett 107: 105-108, 1996. (Pubitemid 26370864)
7. Takano Y, Shiota G and Kawasaki H: Analysis of genomic imprinting of insulin-like growth factor 2 in colorectal cancer. Oncology 59: 210-216, 2000.
8. Nishihara S, Hayashida T, Mitsuya K, Schulz TC, Ikeguchi M, Kaibara N and Oshimura M: Multipoint imprinting analysis in sporadic colorectal cancers with and without microsatellite instability. Int J Oncol 17: 317-322, 2000.
9. Nakagawa H, Chadwick RB, Peltomäki P, Plass C, Nakmaura Y and de La Chapelle A: Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region H19-associated CTCF-binding sites in colorectal cancer. Proc Natl Acad Sci USA 98: 591-596, 2001. (Pubitemid 32105087)
10. Wu MS, Wang HP, Lin CC, Sheu JC, Shun CT, Lee WJ and Lin JT: Loss of imprinting and overexpression of IGF2 gene in gastric adenocarcinoma. Cancer Lett 120: 9-14, 1997.
11. Kim K-S and Lee Y-I: Biallelic expression of the H19 and IGF2 genes in hepatocellular carcinoma. Cancer Lett 119: 143-148, 1997. (Pubitemid 27478096)
12. Nonomura N, Miki T, Nishimura K, Kanno N, Kojima Y and Okuyama A: Altered imprinting of the H19 and insulin-like growth factor II genes in testicular tumors. J Urol 157: 1977-1979, 1997. (Pubitemid 27171823)
13. Mori M, Inoue H, Shiraishi T, Mimori K, Shibuta K, Nakashima H, Mafune K, Tanaka Y, Ueo H, Barnard GF, Sugimachi K and Akiyoshi T: Relaxation of insulin-like growth factor 2 gene imprinting in esophageal cancer. Int J Cancer 68: 441-446, 1996. (Pubitemid 26414497)
14. Cui H, Horon IL, Ohlsson R, Hamilton SR and Feinberg AP: Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. Nat Med 4: 1276-1280, 1998. (Pubitemid 28512108)
15. Ransohoff DF: Cancer Developing molecular biomarkers for cancer. Science 299: 1679-1680, 2003.
16. Emmert-Buck MR, Bonner RF, Smith PD, Chuaqui RF, Zhuang Z, Goldstein SR, Weiss RA and Liotta LA: Laser capture microdissection. Science 274: 998-1001, 1996. (Pubitemid 26398425)
17. Zhu W, Zou H, Beck A, Chervinsky D, Malik D, Brooks JJ and Tan D: Loss of heterozygosity in primary lung cancer using laser capture microdissection and WAVE DNA fragment analysis techniques. Med Sci Monit 8: 95-99, 2002.
18. Bertheau P, Plassa LF, Lerebours F, De Roquancourt A, Turpin E, Lidereau R, De Thé H and Janin A: Allelic loss detection in inflammatory breast cancer: improvement with laser microdissection. Lab Invest 81: 1397-1402, 2001. (Pubitemid 32980162)
19. Uejima H, Lee MP, Cui H and Feinberg AP: Hot-stop PCR: a simple and general assay for linear quantitation of allele ratios. Nat Genet 25: 375-376, 2000. (Pubitemid 32983424)
20. Chomzynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
21. 764-769. Cell Biol Int 29: 521-528, 2000.
22. Hofmann W-K, Takeuchi S, Franzen MA, Hoelzei D and Koeffler HP: Loss of genomic imprinting of insulin-like growth factor 2 is strongly associated with cellular proliferation in normal hematopoietic cells. Exp Hematol 30: 318-323, 2002. (Pubitemid 34286436)
23. He L, Cui H, Walsch C, Mattsson R, Lin W, Anneren G, Pfeifer-Ohlson S and Ohlson R: Hypervariable allelic expression patterns of the imprinted IGF2 gene in tumor cells. Oncogene 16: 113-119, 1998. (Pubitemid 28043515)
24. Yun K, Soejima H, Merrie AE, McCall JL and Reeve AE: Analysis of IGF2 gene imprinting in breast cancer by allele specific-PCR. J Pathol 187: 518-522, 1999. (Pubitemid 29151991)
25. Cui H, Onyango P, Brandenburg S, Wu Y, Hsieh C-L and Feinberg AP: Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2. Cancer Res 62: 6442-6446, 2002. (Pubitemid 35364103)
26. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM and Bos JL: Genetic alterations during colorectal-tumor development. N Engl J Med 319: 525-532, 1988.
27. Cui H, Cruz-Correa M, Giardiello FM, Hutcheon DF, Kafonek DR, Brandenburg S, Wu Y, He X, Powe NR and Feinberg AP: Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science 299: 1753-1755, 2003. (Pubitemid 36337205)